Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Spectral CMO John Kellum
View:
Post by money4golf on Feb 19, 2024 10:45pm

Spectral CMO John Kellum

John Kellum Chief Medical Officer at Spectral Medical Inc.

This is an important milestone --60% trial enrollment. Most trials experience accelerated enrollment from this point. Only 60 more patients to go.
Comment by BlueJays9293 on Feb 19, 2024 11:18pm
Awesome find Money!  As a reluctant LinkedIn user I can confirm that our CMO John Kellum did indeed post this reply to Spectral's recent posting of their major milestone achievement.  Good to hear from Dr. Kellum for sure.  This should temper the irrational chicken little's on SH that got their undies in a bind because Dr. Kellum wasn't quoted in recent PR's. I am ...more  
Comment by mercedesman on Feb 19, 2024 11:48pm
Small Correction .... they had their "panties in a bunch" ... for no good reason ('cept maybe nefarious ones)....as per usual.  No way that JK walks away from a career defining moment like this.   Looking forward to the joint release by Baxter and Spectral coming soon. 
Spectral Medical Inc